Clinical trial
Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early…
NCT00315133 · University of Sao Paulo, Other · Completed
Key facts
| NCT number | NCT00315133 |
|---|---|
| Title | Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus |
| Official title | Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes Mellitus- a Phase I/II Study |
| Lead sponsor | University of Sao Paulo, Other |
| Collaborators | Northwestern University Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Procedure |
| Interventions | Immunosuppression and autologous stem cell transplantation |
| Enrollment | 25 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2014 |
| First posted | Apr 17, 2006 |
| Last update posted | Jan 18, 2017 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: